Continuous Glucose Monitoring Devices Market Size, Share, Growth Analysis, By Component(Transmitters, Sensors, Receivers), By End-Use(Hospitals, Home Care, Others), By Region - Industry Forecast 2024-2031

The competitive landscape of the global continuous glucose monitoring devices market is characterized by intense rivalry among key players aiming to capture a significant share. Industry leaders like Abbott, Dexcom, and Medtronic maintain dominant positions owing to their extensive product portfolios, technological innovation, and established market presence. These companies continuously invest in research and development to enhance device accuracy, user-friendliness, and connectivity.

Numerous entrants and startups are also making waves by introducing disruptive technologies, such as non-invasive monitoring solutions and AI-powered data analysis, which challenge traditional market dynamics. Collaborations between technology giants, healthcare providers, and diabetes care specialists are reshaping the landscape, enabling holistic solutions that encompass devices, software, and personalized patient support.

Continuous Glucose Monitoring Devices Market Top Player’s Company Profiles

• Abbott (USA)

• Dexcom (USA)

• Medtronic (Ireland)

• Roche Diagnostics (Switzerland)

• Senseonics Holdings (USA)

• Lifespan (South Korea)

• Ascensia Diabetes Care (Switzerland)

• Nemaura Medical (UK)

• Ypsomed (Switzerland)

• Glysens (USA)

• Tandem Diabetes Care (USA)

• MedAngel (Belgium)

• Bigfoot Biomedical (USA)

• Novo Nordisk (Denmark)

• Sensionics (USA)

• MicroPort (China)

• Insulet Corporation (USA)

• GluSense (Israel)

• DarioHealth (USA)

• Admetsys (USA)

Continuous Glucose Monitoring Devices Market